B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 17, Issue 7, Pages 399-414
Publisher
Springer Science and Business Media LLC
Online
2021-06-02
DOI
10.1038/s41582-021-00498-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
- (2020) David Schafflick et al. Nature Communications
- Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
- (2020) Sebastian Torke et al. ACTA NEUROPATHOLOGICA
- Ofatumumab versus Teriflunomide in Multiple Sclerosis
- (2020) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defective CD19+CD24hiCD38hi transitional B-cell function in patients with relapsing-remitting MS
- (2020) Maria T Cencioni et al. Multiple Sclerosis Journal
- A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
- (2020) Akshaya Ramesh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis
- (2020) Nitzan Nissimov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cell depletion in the treatment of multiple sclerosis
- (2019) Kjell-Morten Myhr et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
- (2019) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
- (2019) Giancarlo Comi et al. Multiple Sclerosis and Related Disorders
- CD24hiCD38hi and CD24hiCD27+ Human Regulatory B Cells Display Common and Distinct Functional Characteristics
- (2019) Md Mahmudul Hasan et al. JOURNAL OF IMMUNOLOGY
- B cells in autoimmune and neurodegenerative central nervous system diseases
- (2019) Joseph J. Sabatino et al. NATURE REVIEWS NEUROSCIENCE
- Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab
- (2019) Heinz Wiendl et al. Neurology-Neuroimmunology & Neuroinflammation
- Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
- (2019) Amit Bar-Or et al. TRENDS IN MOLECULAR MEDICINE
- Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
- (2018) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Self-Reactive B Cells in the Germinal Center Reaction
- (2018) Robert Brink et al. Annual Review of Immunology
- The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity
- (2018) Jasper Rip et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
- (2018) Keith A Sacco et al. Immunotherapy
- Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production
- (2018) Yoichiro Okada et al. JOURNAL OF AUTOIMMUNITY
- Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis
- (2018) Caterina Veroni et al. Journal of Neuroinflammation
- Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
- (2018) Bryan Ceronie et al. JOURNAL OF NEUROLOGY
- Applying the 2017 McDonald diagnostic criteria for multiple sclerosis – Authors' reply
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Reassessing B cell contributions in multiple sclerosis
- (2018) Rui Li et al. NATURE IMMUNOLOGY
- Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
- (2018) Amit Bar-Or et al. NEUROLOGY
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- Meningeal inflammation and cortical demyelination in acute multiple sclerosis
- (2018) Ryan J. Bevan et al. ANNALS OF NEUROLOGY
- Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis
- (2018) Marina R von Essen et al. BRAIN
- Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study
- (2018) Konrad Rejdak et al. Multiple Sclerosis and Related Disorders
- Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
- (2018) Stefan Gingele et al. Cells
- Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis
- (2017) Fredrika Collins et al. Expert Review of Clinical Immunology
- Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
- (2017) Maria T. Cencioni et al. IMMUNOLOGY
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Poster Session 1
- (2017) Multiple Sclerosis Journal
- Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
- (2017) Nicola De Stefano et al. Multiple Sclerosis Journal
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
- (2017) Paolo A. Muraro et al. Nature Reviews Neurology
- Haematopoietic stem cell transplantation for autoimmune diseases
- (2017) Joost F. Swart et al. Nature Reviews Rheumatology
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
- (2017) Richard A. Nash et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis
- (2017) Maria Pia Sormani et al. NEUROLOGY
- Cladribine to Treat Relapsing Forms of Multiple Sclerosis
- (2017) Gavin Giovannoni Neurotherapeutics
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- The microanatomic segregation of selection by apoptosis in the germinal center
- (2017) Christian T. Mayer et al. SCIENCE
- Poster Session 1
- (2017) Multiple Sclerosis Journal
- Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
- (2017) Nicola De Stefano et al. Multiple Sclerosis Journal
- ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential
- (2016) Tobias Ruck et al. BMC Neurology
- The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
- (2016) Lukas Haider et al. BRAIN
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
- (2016) Harold L Atkins et al. LANCET
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- The effects of intrathecal rituximab on biomarkers in multiple sclerosis
- (2016) Joanne Topping et al. Multiple Sclerosis and Related Disorders
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
- (2016) Kristbjörg Bjarnadóttir et al. Scientific Reports
- Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
- (2015) T. R. W. Tipton et al. BLOOD
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
- (2015) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy
- (2015) Chao Quan et al. JOURNAL OF NEUROIMMUNOLOGY
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects
- (2015) Per Soelberg Sorensen et al. Therapeutic Advances in Neurological Disorders
- Mode of action and clinical studies with alemtuzumab
- (2014) Joanne L. Jones et al. EXPERIMENTAL NEUROLOGY
- T cell repertoire following autologous stem cell transplantation for multiple sclerosis
- (2014) Paolo A. Muraro et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
- (2014) Thomas P Leist et al. LANCET NEUROLOGY
- Multiple sclerosis genetics
- (2014) Stephen Sawcer et al. LANCET NEUROLOGY
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
- (2014) Clementina E. Cocuzza et al. PLoS One
- Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology
- (2013) Gabriele C. DeLuca et al. BRAIN
- Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats
- (2013) Christopher Gardner et al. BRAIN
- Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis
- (2013) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis
- (2013) Yahya H. Almohmeed et al. PLoS One
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity
- (2012) Michael A. Maurer et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell exchange across the blood-brain barrier in multiple sclerosis
- (2012) H.-Christian von Büdingen et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
- (2012) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study
- (2012) Giancarlo Comi et al. JOURNAL OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
- (2012) R Saccardi et al. Multiple Sclerosis Journal
- B cells and antibodies in multiple sclerosis pathogenesis and therapy
- (2012) Markus Krumbholz et al. Nature Reviews Neurology
- The anti-CD20 antibody rituximab reduces the Th17 cell response
- (2011) Frank L. van de Veerdonk et al. ARTHRITIS AND RHEUMATISM
- Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
- (2011) J D Bowen et al. BONE MARROW TRANSPLANTATION
- Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
- (2011) H. Lassmann et al. BRAIN
- Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
- (2011) Laura Lovato et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells
- (2011) Camille L. Pittet et al. GLIA
- Mice Lacking Endogenous IL-10-Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells
- (2011) N. A. Carter et al. JOURNAL OF IMMUNOLOGY
- Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission
- (2011) Stephanie Knippenberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
- (2011) Klaus Lehmann-Horn et al. Journal of Neuroinflammation
- Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
- (2011) Grant A Hill-Cawthorne et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
- (2011) Gavin Giovannoni et al. LANCET NEUROLOGY
- Prevention and treatment of MS: studying the effects of vitamin D
- (2011) Kassandra L Munger et al. Multiple Sclerosis Journal
- Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
- (2011) GL Mancardi et al. Multiple Sclerosis Journal
- Association of innate immune activation with latent Epstein-Barr virus in active MS lesions
- (2011) J. S. Tzartos et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
- (2010) Géraldine Androdias et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Detection of Epstein–Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look
- (2010) Francesca Aloisi et al. BRAIN
- Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
- (2010) Joanne L. Jones et al. BRAIN
- Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis
- (2010) Roberta Mancuso et al. JOURNAL OF MEDICAL VIROLOGY
- A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
- (2010) Avijit Ray et al. JOURNAL OF NEUROIMMUNOLOGY
- Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation
- (2010) Barbara Serafini et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
- (2010) Stephen A. Beers et al. SEMINARS IN HEMATOLOGY
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis
- (2009) Laura A. N. Peferoen et al. BRAIN
- Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain
- (2009) Simon N. Willis et al. BRAIN
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
- (2008) T. Alexander et al. BLOOD
- Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody
- (2008) Wim K. Bleeker et al. BRITISH JOURNAL OF HAEMATOLOGY
- B lymphocytes - chief players and therapeutic targets in autoimmune diseases
- (2008) Moncef Zouali Frontiers in Bioscience-Landmark
- EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
- (2008) Jan D. Lünemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autologous haematopoietic stem-cell transplantation in multiple sclerosis
- (2008) Gianluigi Mancardi et al. LANCET NEUROLOGY
- Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
- (2008) Birgit Obermeier et al. NATURE MEDICINE
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started